SIMETHICONE Side Effects

5608904-9 | Aphasia, Cerebrovascular Accident, Hyperglycaemia, Hyperosmolar State, Monoplegia, Muscular Weakness, Mutism
on Jan 22, 2008 Female patient from TAIWAN, PROVINCE OF CHINA , 71 years of age, weighting 134.5 lb, was diagnosed with constipation (What is constipation?), gastric ulcer, hypertension, hyperlipidaemia, irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Simethicone (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cerebrovascular accident, hyperglycaemia, hyperosmolar state, monoplegia, muscular weakness, mutism. Simethicone dosage: . During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), PANTOLOC (View Pantoloc Review and Pantoloc Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ISRADIPINE (View Isradipine Review and Isradipine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), INSULIN (View Insulin Review and Insulin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ZELMAC (6 Mg, Bid) (View Zelmac Review and Zelmac Label ). Patient was hospitalized.

5526932-9 | Ascites, Atrial Fibrillation, Chest Pain, Disease Progression, Ejection Fraction Decreased, Electrocardiogram Repolarisation Abnormality, Fungal Infection, Haematocrit Decreased, Haemoglobin Decreased
Patient was taking Simethicone (View Usage). Patient had the following side effects: ascites, atrial fibrillation (What is atrial fibrillation?), chest pain (What is chest pain?), disease progression, ejection fraction decreased, electrocardiogram repolarisation abnormality, fungal infection (What is fungal infection?), haematocrit decreased, haemoglobin decreased on Nov 19, 2007 from UNITED STATES Additional patient health information: Male patient , 72 years of age, . Simethicone dosage: Unk. During the same period patient was treated with COLACE (Unk) (View Colace Review and Colace Label ), LACTULOSE (Unk) (View Lactulose Review and Lactulose Label ), MS CONTIN (Unk) (View Ms Contin Review and Ms Contin Label ), TEGAFUR (Unk) (View Tegafur Review and Tegafur Label ), GIMERACIL (Unk) (View Gimeracil Review and Gimeracil Label ), BEVACIZUMAB (Unk) (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5525941-3 | Ascites, Disease Progression, Pleural Effusion, Pneumonia, Pneumopericardium
Adverse event was reported on Nov 14, 2007 by a Male patient taking Simethicone (View Usage) (Dosage: Unk) . Location: UNITED STATES , 72 years of age, After Simethicone was administered, patient had the following side effects: ascites, disease progression, pleural effusion, pneumonia (What is pneumonia?), pneumopericardium. During the same period patient was treated with COLACE (Unk) (View Colace Review and Colace Label ), LACTULOSE (Unk) (View Lactulose Review and Lactulose Label ), MS CONTIN (Unk) (View Ms Contin Review and Ms Contin Label ), TEGAFUR (Unk) (View Tegafur Review and Tegafur Label ), GIMERACIL (Unk) (View Gimeracil Review and Gimeracil Label ), BEVACIZUMAB (Unk) (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5493117-4 | Ascites, Pleural Effusion, Pneumonia, Pneumopericardium
on Oct 17, 2007 Male patient from UNITED STATES , 72 years of age, was treated with Simethicone (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, pleural effusion, pneumonia (What is pneumonia?), pneumopericardium. Simethicone dosage: Unk. During the same period patient was treated with COLACE (Unk) (View Colace Review and Colace Label ), LACTULOSE (Unk) (View Lactulose Review and Lactulose Label ), MS CONTIN (Unk) (View Ms Contin Review and Ms Contin Label ), TEGAFUR (Unk) (View Tegafur Review and Tegafur Label ), GIMERACIL (Unk) (View Gimeracil Review and Gimeracil Label ), BEVACIZUMAB (Unk) (View Bevacizumab Review and Bevacizumab Label ), OXALIPLATIN (Unk) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.


5417914-6 | Aphasia, Cerebrovascular Accident, Hyperglycaemia, Hyperosmolar State, Monoplegia, Muscular Weakness, Mutism
on Aug 08, 2007 Female patient from TAIWAN, PROVINCE OF CHINA , 71 years of age, weighting 134.5 lb, was diagnosed with constipation (What is constipation?), gastric ulcer, hypertension, hyperlipidaemia, type 2 diabetes mellitus, irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Simethicone (View Usage). Patient had the following side effects: aphasia (What is aphasia?), cerebrovascular accident, hyperglycaemia, hyperosmolar state, monoplegia, muscular weakness, mutism. Simethicone dosage: . During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ISRADIPINE (View Isradipine Review and Isradipine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), INSULIN (View Insulin Review and Insulin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ZELNORM (6 Mg, Bid) (View Zelnorm Review and Zelnorm Label ). Patient was hospitalized.